Possible role for acetylcysteine as a treatment for acute liver failure secondary to antitubercular medication use.
CONCLUSION: Given the limited number of therapeutic interventions shown to be beneficial in ALF and data suggesting a protective effect against DILI with initiation of acetylcysteine at the start of treatment with anti-TB medications, acetylcysteine can be considered for patients with anti-TB - associated DILI.
PMID: 32885827 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Fox AN, Nation BE, Autry MT, Johnson PN Tags: Am J Health Syst Pharm Source Type: research
More News: Acetaminophen | Acetylcysteine | Clinical Trials | Drugs & Pharmacology | Liver | Liver Transplant | Lortab | Toxicology | Transplant Surgery | Transplants | Tuberculosis | Urology & Nephrology